![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
F Menzaghi, RL Howard, SC Heinrichs, W Vale, J Rivier and GF Koob
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California.
The present study examined the ability of two analogs of human/rat corticotropin-releasing factor (h/rCRF), [Met18, Lys23, Glu27,29,40, Ala32,41, Leu33,36,38] h/rCRF9-41 (alpha-hel CRF9-41) and [D-Phe12, Nle21,38, C alpha MeLeu37] h/rCRF12-41 (D-Phe CRF12-41), to antagonize CRF- and stress-induced behavioral changes in rats. The potency and duration of action of D-Phe CRF12-41 in vivo was compared with that of alpha-hel CRF9-41, the most effective CRF antagonist studied to date. When administered i.c.v., both CRF antagonists dose-dependently reduced the locomotor activity induced by rat CRF (0.5 microgram/rat i.c.v.) and attenuated the social stress-induced anxiogenic-like effect, as measured by the elevated plus-maze. However D-Phe CRF12-41 was 5 times more potent and remained effective for a longer period (> 1.5 hr) than alpha-hel CRF9-41. High doses of alpha-hel CRF9-41 (25 micrograms/rat), by itself, exhibited weak agonist effects, which were not observed with D-Phe CRF12-41 at the same doses. These results demonstrate that a N- terminus-shortened CRF antagonist that encompasses the substitution D- Phe12 has significantly higher biological potency and an extended duration of action without intrinsic agonist effects in these in vivo systems. The availability of potent and effective CRF antagonists will provide valuable tools for exploring the functional role of brain CRF and may ultimately lead to an understanding of the biological basis of stress-related illnesses.
This article has been cited by other articles:
|
|
 |
|
  J. R. Miragaya and R. B. S. Harris Antagonism of corticotrophin-releasing factor receptors in the fourth ventricle modifies responses to mild but not restraint stress Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R404 - R416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. N. Richardson, E. P. Zorrilla, C. D. Mandyam, and C. L. Rivier Exposure to Repetitive Versus Varied Stress during Prenatal Development Generates Two Distinct Anxiogenic and Neuroendocrine Profiles in Adulthood Endocrinology, May 1, 2006; 147(5): 2506 - 2517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Carlin, W. W. Vale, and T. L. Bale Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis PNAS, February 28, 2006; 103(9): 3462 - 3467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Stiedl, M. Meyer, O. Jahn, S. O. Ogren, and J. Spiess Corticotropin-Releasing Factor Receptor 1 and Central Heart Rate Regulation in Mice during Expression of Conditioned Fear J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 905 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Heinrichs and G. F. Koob Corticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 427 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Jedema and A. A. Grace Corticotropin-Releasing Hormone Directly Activates Noradrenergic Neurons of the Locus Ceruleus Recorded In Vitro J. Neurosci., October 27, 2004; 24(43): 9703 - 9713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Y. Lu, G. S. Barsh, H. Akil, and S. J. Watson Interaction between {alpha}-Melanocyte-Stimulating Hormone and Corticotropin-Releasing Hormone in the Regulation of Feeding and Hypothalamo-Pituitary-Adrenal Responses J. Neurosci., August 27, 2003; 23(21): 7863 - 7872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Bale, K. R. Anderson, A. J. Roberts, K.-F. Lee, T. R. Nagy, and W. W. Vale Corticotropin-Releasing Factor Receptor-2-Deficient Mice Display Abnormal Homeostatic Responses to Challenges of Increased Dietary Fat and Cold Endocrinology, June 1, 2003; 144(6): 2580 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pelleymounter, M. Joppa, N. Ling, and A. C. Foster Pharmacological Evidence Supporting a Role for Central Corticotropin-Releasing Factor2 Receptors in Behavioral, but not Endocrine, Response to Environmental Stress J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 145 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Bale, K.-F. Lee, and W. W. Vale The Role of Corticotropin-Releasing Factor Receptors in Stress and Anxiety Integr. Comp. Biol., July 1, 2002; 42(3): 552 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Griebel, J. Simiand, R. Steinberg, M. Jung, D. Gully, P. Roger, M. Geslin, B. Scatton, J.-P. Maffrand, and P. Soubrie 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 333 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Bakshi, S. Smith-Roe, S. M. Newman, D. E. Grigoriadis, and N. H. Kalin Reduction of Stress-Induced Behavior by Antagonism of Corticotropin-Releasing Hormone 2 (CRH2) Receptors in Lateral Septum or CRH1 Receptors in Amygdala J. Neurosci., April 1, 2002; 22(7): 2926 - 2935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Graziani, L. Tentori, I. Portarena, M. Barbarino, G. Tringali, G. Pozzoli, and P. Navarra CRH Inhibits Cell Growth of Human Endometrial Adenocarcinoma Cells via CRH-Receptor 1-Mediated Activation of cAMP-PKA Pathway Endocrinology, March 1, 2002; 143(3): 807 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. MacNeil, A. H. Jansen, A. H. Greenberg, and D. M. Nance Effect of acute adrenalectomy on sympathetic responses to peripheral lipopolysaccharide or central PGE2 Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1321 - R1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Okuyama, S. Chaki, N. Kawashima, Y. Suzuki, S.-I. Ogawa, A. Nakazato, T. Kumagai, T. Okubo, and K. Tomisawa Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001 J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 926 - 935. [Abstract] [Full Text]
|
|
|
|
|
|
F.-C. Chang and M. R. Opp Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R793 - R802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Yu and P. Shinnick-Gallagher Corticotropin-Releasing Factor Increases Dihydropyridine- and Neurotoxin-Resistant Calcium Currents in Neurons of the Central Amygdala J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 170 - 179. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Walker and G. F. Koob Orphan anxiety PNAS, December 23, 1997; 94(26): 14217 - 14219. [Full Text] [PDF]
|
|
|
|
|
|
D. N. Cortright, K. A. Goosens, J. Shonee Lesh, and A. F. Seasholtz Isolation and Characterization of the Rat Corticotropin-Releasing Hormone (CRH)-Binding Protein Gene: Transcriptional Regulation by Cyclic Adenosine Monophosphate and CRH Endocrinology, May 1, 1997; 138(5): 2098 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shaham, D. Funk, S. Erb, T. J. Brown, C.-D. Walker, and J. Stewart Corticotropin-Releasing Factor, But Not Corticosterone, Is Involved in Stress-Induced Relapse to Heroin-Seeking in Rats J. Neurosci., April 1, 1997; 17(7): 2605 - 2614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Martínez, J. Rivier, L. Wang, and Y. Taché Central Injection of a New Corticotropin-Releasing Factor (CRF) Antagonist, Astressin, Blocks CRF- and Stress-Related Alterations of Gastric and Colonic Motor Function J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 754 - 760. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Spina, E. Merlo-Pich, R. K. W. Chan, A. M. Basso, J. Rivier, W. Vale, and G. F. Koob Appetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide Science, September 13, 1996; 273(5281): 1561 - 1564. [Abstract]
|
|
|
|
|
|
S. Erb and J. Stewart A Role for the Bed Nucleus of the Stria Terminalis, But Not the Amygdala, in the Effects of Corticotropin-Releasing Factor on Stress-Induced Reinstatement of Cocaine Seeking J. Neurosci., October 15, 1999; 19(20): RC35 - RC35. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
